Veradigm (NASDAQ:MDRX) Receives New Coverage from Analysts at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX) in a research note issued on Saturday. The firm set a “hold” rating on the software maker’s stock.

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $10.00 target price (down previously from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $11.25.

Veradigm Price Performance

Shares of Veradigm stock opened at $7.55 on Friday. The company’s 50-day moving average price is $7.79 and its 200-day moving average price is $9.14. Veradigm has a 12-month low of $5.01 and a 12-month high of $14.09.

Institutional Trading of Veradigm

Hedge funds have recently bought and sold shares of the stock. TFO Wealth Partners LLC raised its holdings in shares of Veradigm by 105,280.0% during the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after acquiring an additional 5,264 shares in the last quarter. Gladius Capital Management LP grew its holdings in Veradigm by 135.0% in the fourth quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after purchasing an additional 3,587 shares during the last quarter. Meadow Creek Wealth Advisors LLC purchased a new stake in shares of Veradigm during the first quarter worth about $83,000. Headlands Technologies LLC lifted its stake in shares of Veradigm by 14,907.7% during the fourth quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock worth $102,000 after buying an additional 9,690 shares during the period. Finally, Covestor Ltd lifted its holdings in shares of Veradigm by 10.3% during the third quarter. Covestor Ltd now owns 10,336 shares of the software maker’s stock worth $136,000 after purchasing an additional 966 shares during the period.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.